Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,036.90down ₹31.90 (2.98%)BSE ₹1,037.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,068.80.
2 Nov: open ₹1,067.30, high ₹1,067.30, low ₹1,013.90
52-week range of traded prices to 2 Nov 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,557 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,07,98637.7% delivered
Strides Pharma Science orders, deals and press releases
485 filed, newest first. Page 7 of 10.
Feb 2013
19 Feb · Business
Company has allotted 81,650 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 589,245,210/- consisting of 58,924,521 equity shares of Rs. 10/- each to Rs. 590,061,710/- consisting of 59,006,171 equity shares of Rs. 10/- each.12 Feb · Business
Company has allotted 120,800 fully paid equity shares of Rs. 10/- each on conversion of employees stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 588,037,210/- consisting of 58,803,721 equity shares of Rs. 10/- each to Rs. 589,245,210/- consisting of 58,924,521 equity shares of Rs. 10/- each.
Dec 2012
Nov 2012
Oct 2012
19 Oct · Business
Company has allotted 65,000 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs.587,387,210/- consisting of 58,738,721 equity shares of Rs.10/- each to Rs.588,037,210/- consisting of 58,803,721 equity shares of Rs.10/- each.
Sep 2012
26 Sep · Business
Company has allotted 15,000 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs.587,237,210/- consisting of 58,723,721 equity shares of Rs.10/- each to Rs.587,387,210/- consisting of 58,738,721equity shares of Rs.10/- each.10 Sep · Business
Company has allotted 27,250 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs.586,964,710/- consisting of 58,696,471 equity shares of Rs.10/- each to Rs.587,237,210/- consisting of 58,723,721 equity shares of Rs.10/- each.
Aug 2012
Jul 2012
Jun 2012
26 Jun · Business
Company has allotted 31,200 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs.586,652,710/- consisting of 58,665,271 equity shares of Rs.10/- each to Rs.586,964,710/- consisting of 58,696,471 equity shares of Rs.10/- each.
May 2012
Apr 2012
18 Apr · Business
Company has allotted 125,000 fully paid equity shares of Rs.10/- each under Strides Arcolab ESOP 2008 (Directors) Scheme to Non-Executive Directors of the Company. Consequent to the allotment, the paid-up equity share capital of the Company has increased from Rs.585,402,710.00 consisting of 58,540,271 equity shares of Rs.10/- each to Rs.586,652,710.00 consisting of 58,665,271 equity shares of Rs.10/- each.
Mar 2012
20 Mar · Business
Company has allotted 2,500 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs.585,377,710/- consisting of 58,537,771 equity shares of Rs.10/- each to Rs.585,402,710/- consisting of 58,540,271 equity shares of Rs.10/- each.12 Mar · Business
Company has alloted 36,200 fully paid equity shares of Rs 10/- each on conversion of employee stock options under Strides Arcolab ESOP schemes. Consequent to the above allotment , the paid-up equity share capital of the company has increased from 585,015,710/- consisting of 58,501,571 eqity shares of Rs 10/- each to Rs 585,377,710 /- consisting of 58,537,771 equity shares of Rs 10/- each.2 Mar · Business
Company has allotted 30,400 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 584,711,710/- consisting of 58,471,171 equity shares of Rs.10/- each to Rs.585,015,710/- consisting of 58,501,571 equity shares of Rs.10/- each.
Feb 2012
24 Feb · Business
Company has allotted 57,750 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 584,134,210/- consisting of 58,413,421 equity shares of Rs.10/- each to Rs. 584,711,710/- consisting of 58,471,171 equity shares of Rs.10/- each.14 Feb · Business
Company has allotted 14,500 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 583,989,210/- consisting of 58,398,921 equity shares of Rs.10/- each to Rs. 584,134,210/- consisting of 58,413,421 equity shares of Rs.10/- each.6 Feb · Business
Company has allotted 18,750 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 583,801,710/- consisting of 58,380,171 equity shares of Rs. 10/- each to Rs. 583,989,210 consisting of 58,398,921equity shares of Rs. 10/- each.
Jan 2012
Dec 2011
Nov 2011
Oct 2011
17 Oct · Business
Company has allotted 6,000 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 583,741,710/- consisting of 58,374,171 equity shares of Rs. 10/- each to Rs. 583,801,710 consisting of 58,380,171 equity shares of Rs. 10/- each.
Sep 2011
29 Sep · Business
Company has allotted 38,250 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 583,359,710/- consisting of 583,335,921 equity shares of Rs. 10/- each to Rs. 583,741,710 consisting of 58,374,171 equity shares of Rs. 10/- each.16 Sep · Business
Company has allotted 29,250 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 583,066,710/- consisting of 58,306,671 equity shares of Rs. 10/- each to Rs. 583,359,210 consisting of 58,335,921 equity shares of Rs. 10/- each.